Kwivik Therapeutics Inc Stock
Medtech
Sign up today and learn more about Kwivik Therapeutics Inc Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Kwivik Therapeutics Inc Stock
Kwivik Therapeutics Inc. is a pre-IPO medtech company that has developed a way to create medical oxygen from two, dry inert powders. The oxygen is created on demand, without the need for pressurized storage. We combined this "oxygen from powder" technology with innovative biotech, engineering, IoT and AI technologies to develop a robust pipeline of products to disrupt certain respiratory, emergency medical, asthma, cluster headache/migraine, wound care and skin care markets globally, with a combined market size exceeding $750 Billion.
Investors
Funding History
| October 2018 | $50.0M |
|---|
Management
Chief Executive Officer
Julian Ross, MBA
Chief Financial Officer
Jeff Robertson, CPA, CGMA
Chief Medical Officer
Luis Salmun, MD
Chief Information Officer
Ronald Redmer
Press
finance - Jan, 13 2021
Kwivik Therapeutics Partners with EirMed to Accelerate Product CommercializationMedical Device Network - Jan, 4 2021
Largest players in MedTech industry embrace artificial intelligenceMedTech Dive - Jan, 4 2021
Brexit deal creates regulatory barriers to UK-EU medical device tradeForbes - Dec, 31 2020
How Medtech Is Reshaping Continuing Education In The Medical ProfessionEquityZen Recognized As:
